Jiangsu Hengrui Medicine
600276.SS
#494
Rank
NZ$71.50 B
Marketcap
$11.21
Share price
-0.62%
Change (1 day)
13.08%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$11.18 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has NZ$11.18 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$NZ$8.77 B7.34%
2021-12-31$NZ$8.17 B24.93%
2020-12-31$NZ$6.54 B23.42%
2019-12-31$NZ$5.30 B22.72%
2018-12-31$NZ$4.31 B25.18%
2017-12-31$NZ$3.45 B28.92%
2016-12-31$NZ$2.67 B14.63%
2015-12-31$NZ$2.33 B38.93%
2014-12-31$NZ$1.68 B25.58%
2013-12-31$NZ$1.33 B26.13%
2012-12-31$NZ$1.06 B18.87%
2011-12-31$NZ$0.89 B31.05%
2010-12-31$NZ$0.68 B26.8%
2009-12-31$NZ$0.53 B4.91%
2008-12-31$NZ$0.51 B72.82%
2007-12-31$NZ$0.29 B28.55%
2006-12-31$NZ$0.23 B14.69%
2005-12-31$NZ$0.20 B18.76%
2004-12-31$NZ$0.16 B0.66%
2003-12-31$NZ$0.16 B-10.1%
2002-12-31$NZ$0.18 B-15.22%
2001-12-31$NZ$0.22 B